Maryland · Public charity
Aeras
AERAS is a non-profit product development organization dedicated to the development of effective tuberculosis (tb) vaccines and biologics to prevent tb across all age groups in an affordable and sustainable manner. AERAS utilizes its broad capabilities and technologies in collaboration with numerous partners and stakeholders to support…
- $4.0M
- Granted FY2018
- 1
- Itemized grants FY2018
- 1
- Organizations funded FY2018
- Itemized, FY2018
- $2.2M
- The rest is grants the schedule does not break out
- Median grant, FY2018
- $2,231,014
- Largest grant, FY2018
- $2,231,014
- States reached, FY2018
- 1
- Total assets, FY2018
- $3.3M
Top grantees
Largest recipients by total granted, FY2018 to FY2018, and the share of each one’s budget the grants supplied at peak.
| Grantee | Total granted | Years | Share of their budget |
|---|---|---|---|
| International AIDS Vaccine Initiative Inc | $2,231,014 | 1 | 3% |
About Aeras
- How much does Aeras give?
- Aeras reported 1 itemized grants totaling $2,231,014, out of $3,990,465 in total grant expense reported on the return in its FY2018 IRS filing.
- What does Aeras fund?
- By grant dollars over FY2018 to FY2018, its largest causes are International (100%).
- Who are Aeras's largest grantees?
- By total granted over FY2018 to FY2018: International AIDS Vaccine Initiative Inc ($2.2M).
- Where is Aeras based?
- Aeras is based in MD.
Play a game based on Aeras’ filings →
More from the funding graph
The unnamed billions
grants reported with no recipient in the public record
The regranting layer
51% of grant dollars land in the regranting layer
The DAF merry-go-round
$9.7B circulates between donor-advised funds
The endowment market
who holds foundation money, and what just moved
The camps
funders cluster by geography, not ideology
By state
where grant money is based, and what stays home